NasdaqGS:CASY
NasdaqGS:CASYConsumer Retailing

Is Casey's (CASY) Still Undervalued? A Fresh Look at Its Valuation After Recent Momentum

Casey's General Stores (CASY) has stayed on investors' radars following its 7% gain over the past three months. Many are now closely watching how recent performance could shape the stock’s next steps. See our latest analysis for Casey's General Stores. Momentum has clearly been building for Casey’s General Stores, with a 38.94% year-to-date share price return and a strong 33.79% total shareholder return over the last 12 months. Recent moves show that its performance has outpaced many peers...
NYSE:MTD
NYSE:MTDLife Sciences

Does Mettler-Toledo’s (MTD) Ongoing Buybacks and Acquisitions Reflect Evolving Capital Allocation Priorities?

Mettler-Toledo International recently reported its third quarter results, highlighting sales of US$1,029.7 million and ongoing share repurchases, while also raising its 2025 sales guidance and confirming further investments in small, targeted acquisitions. Management reiterated a clear capital allocation focus, favoring buybacks and bolt-on acquisitions such as the Genie Vortex mixers to strengthen and diversify the company's life sciences portfolio. We'll explore how the company's...
NYSE:ESNT
NYSE:ESNTDiversified Financial

How Might Essent Group’s (ESNT) Share Buyback and Dividend Affirmation Shape Its Value Strategy?

In recent news, Essent Group Ltd. completed US$353.91 million in share repurchases, affirmed a US$0.31 per share quarterly dividend, and reported third quarter 2025 earnings, with basic earnings per share slightly up year-over-year despite a marginal decline in net income and revenue. This combination of capital return activity and stable per-share earnings performance highlights management's ongoing focus on both shareholder value and operational discipline. We'll examine how the company's...
NYSE:DEI
NYSE:DEIOffice REITs

Is Douglas Emmett's (DEI) Shift Toward Multifamily a Response to Office Leasing Headwinds?

Earlier this month, Douglas Emmett reported lower-than-expected office leasing activity in the previous quarter due to a pronounced slowdown through September, while noting stronger-than-anticipated lease renewals and tenant retention. Despite near-term softness in office leasing, multifamily operations continued to show robust growth, highlighted by a nearly 7% year-over-year rise in same-store cash NOI and plans to add over 1,000 new high-end residential units in Brentwood and...
NYSE:CVS
NYSE:CVSHealthcare

Is CVS Health a Bargain After Its 76% Rally in 2025?

Curious if CVS Health is a bargain or overpriced right now? You are not alone in wondering whether there is real value hiding in this well-known stock. Shares have surged an impressive 76.3% year-to-date and are up 45.7% over the past year, even as recent weeks brought some turbulence with a -2.4% dip in the last 7 days and a -5.6% move over the last month. Recent headlines have spotlighted CVS Health’s expanding role in healthcare services, such as its bold push into primary care and...
NYSE:AMPX
NYSE:AMPXElectrical

Will Amprius Technologies’ (AMPX) Korea Alliance Reinforce Its Global Manufacturing Ambitions?

Amprius Technologies, Inc. recently announced the formation of the Amprius Korea Battery Alliance, a collaborative initiative to expand global manufacturing, secure supply chain partners, and support over 2.0 GWh of worldwide contract manufacturing capacity by engaging multiple Korean battery industry leaders. The alliance aims to combine Amprius' silicon anode technology with Korea's manufacturing strengths and strengthen the supply network supporting the electric mobility and clean energy...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck (MRK) Is Up 6.0% After Dividend Boost, Positive Trial Results, and Cidara Acquisition Announcement – Has The Bull Case Changed?

In November 2025, Merck announced a quarterly dividend increase and released positive clinical trial results for both WINREVAIR in pulmonary hypertension and enlicitide, its investigational oral PCSK9 inhibitor, alongside updates on a share buyback and the planned acquisition of Cidara Therapeutics for US$9.2 billion. The promising outcomes for WINREVAIR and enlicitide, both targeting significant unmet needs in cardiovascular and pulmonary health, signal Merck's ongoing commitment to...
NYSE:CRCL
NYSE:CRCLSoftware

Are Regulatory Pressure and Insider Moves Shaping Circle (CRCL)’s Competitive Edge in Stablecoins?

Circle Internet Group, Inc. recently reported its third quarter and nine-month financial results and participated in Citi’s 14th Annual FinTech Conference in New York, with CEO Jeremy Allaire addressing industry challenges. The company’s results highlighted a period marked by substantial earnings growth in the latest quarter, but also underscored investor concerns about regulatory pressures, competitive dynamics in the stablecoin market, and insider selling activity. We’ll examine how...
NYSE:TMO
NYSE:TMOLife Sciences

What Thermo Fisher Scientific (TMO)'s FDA Clearance for EXENT System Means for Shareholders

Thermo Fisher Scientific has received FDA 510(k) clearance for its EXENT System, an automated platform designed to enhance the diagnosis of multiple myeloma and related blood disorders by improving result accuracy and clinical workflow efficiency for laboratories in the U.S. and several international markets. This regulatory milestone expands Thermo Fisher’s commercial reach in the diagnostics sector, reflecting how innovation in laboratory automation can influence patient care and clinical...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

A Look at Copart (CPRT) Valuation as Investors Watch for Slower Revenue Growth

Copart (CPRT) is set to announce its earnings this Thursday after the market closes. There is heightened interest this time as observers expect revenue growth to be slower than in recent years. See our latest analysis for Copart. Copart’s share price has struggled this year, with a 30-day return of -7.7% leading into earnings and a year-to-date decline of 26.6%, as the market prices in slowing growth expectations. While the pendulum has swung sharply from its recent highs, long-term total...
NYSE:ENR
NYSE:ENRHousehold Products

Will Energizer (ENR) Overcome Margin Pressures as 2026 Outlook Signals Uncertainty?

Energizer Holdings recently reported full-year 2025 earnings results, highlighting a rise in annual sales to US$2.95 billion and a substantial increase in net income compared to the previous year, but quarterly earnings for the fourth quarter missed analyst expectations. While the company pointed to progress from cost-saving initiatives and international growth, its guidance for fiscal 2026 signals uncertainty ahead due to tariff pressures, softer consumer demand, and ongoing supply chain...
NasdaqGS:MSTR
NasdaqGS:MSTRSoftware

US Stock Market Today: S&P 500 Futures Inch Up as Job Market Cools

The Morning Bull - US Market Morning Update Wednesday, Nov, 19 2025 US stock futures are pointing slightly higher this morning as investors weigh fresh signals from the bond and job markets. The interest paid on 10-year government bonds has slipped to about 4.10%, which often means investors are feeling on edge ahead of new economic reports, especially a key update on job trends. That news comes alongside a bump in people seeking new unemployment benefits, with 232,000 claims registered last...